Hamizah Sulaiman, Roslida A H, Fezah O, Tan K L, Tor Y S, Tan C I
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Asian Pac J Cancer Prev. 2012;13(6):2533-9. doi: 10.7314/apjcp.2012.13.6.2533.
Annona muricata L (Annonaceae), commonly known as soursop has a long, rich history in herbal medicine with a lengthy recorded indigenous use. It had also been found to be a promising new anti-tumor agent in numerous in vitro studies. The present investigation concerns chemopreventive effects in a two-stage model of skin papillomagenesis. Chemopreventive effects of an ethanolic extract of A. muricata leaves (AMLE) was evaluated in 6-7 week old ICR mice given a single topical application of 7,12-dimethylbenza(α)anthracene (DMBA 100 μg/100 μl acetone) and promotion by repeated application of croton oil (1% in acetone/ twice a week) for 10 weeks. Morphological tumor incidence, burden and volume were measured, with histological evaluation of skin tissue. Topical application of AMLE at 30, 100 and 300 mg/kg significantly reduced DMBA/croton oil induced mice skin papillomagenesis in (i) peri-initiation protocol (AMLE from 7 days prior to 7 days after DMBA), (ii) promotion protocol (AMLE 30 minutes after croton oil), or (iii) both peri-initiation and promotion protocol (AMLE 7 days prior to 7 day after DMBA and AMLE 30 minutes after croton oil throughout the experimental period), in a dose dependent manner (p<0.05) as compared to carcinogen-treated control. Furthermore, the average latent period was significantly increased in the AMLE-treated group. Interestingly, At 100 and 300 mg/ kg, AMLE completely inhibited the tumor development in all stages. Histopathological study revealed that tumor growth from the AMLE-treated groups showed only slight hyperplasia and absence of keratin pearls and rete ridges. The results, thus suggest that the A.muricata leaves extract was able to suppress tumor initiation as well as tumor promotion even at lower dosage.
刺果番荔枝(番荔枝科),俗称刺果番荔枝,在草药医学中有着悠久而丰富的历史,有长期的本土使用记录。在众多体外研究中,它也被发现是一种有前景的新型抗肿瘤药物。本研究关注其在皮肤乳头瘤发生两阶段模型中的化学预防作用。对6 - 7周龄的ICR小鼠进行实验,单次局部涂抹7,12 - 二甲基苯并(a)蒽(DMBA,100μg/100μl丙酮),并通过每周两次重复涂抹巴豆油(1%丙酮溶液)进行促癌处理,持续10周。测量形态学肿瘤发生率、负担和体积,并对皮肤组织进行组织学评估。分别在(i)起始前期方案(DMBA处理前7天至处理后7天给予刺果番荔枝叶乙醇提取物(AMLE));(ii)促癌方案(巴豆油处理后30分钟给予AMLE);或(iii)起始前期和促癌方案(整个实验期间,DMBA处理前7天至处理后7天给予AMLE,且巴豆油处理后30分钟给予AMLE)中,以30、100和300mg/kg的剂量局部涂抹AMLE,与致癌物处理的对照组相比,均以剂量依赖方式显著降低了DMBA/巴豆油诱导的小鼠皮肤乳头瘤发生(p<0.05)。此外,AMLE处理组的平均潜伏期显著延长。有趣的是,在100和300mg/kg剂量下,AMLE完全抑制了各个阶段的肿瘤发展。组织病理学研究表明,AMLE处理组的肿瘤生长仅表现为轻微增生,且无角质珠和 rete 嵴。因此,结果表明刺果番荔枝叶提取物即使在较低剂量下也能够抑制肿瘤起始和肿瘤促进。